<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We tested the hypothesis that <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral arteriospasm</z:e> developing after rupture of a subarachnoid <z:hpo ids='HP_0002617'>aneurysm</z:hpo> may be due to the vasoconstrictor effect of locally generated <z:chebi fb="0" ids="2719,48432">angiotensin II</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Ten dogs had <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> simulated by intracisternal introduction of 2 ml autologous blood, and were followed by cineangiography </plain></SENT>
<SENT sid="2" pm="."><plain>Thirty minutes later, when <z:hpo ids='HP_0011009'>acute</z:hpo> arteriospasm was established, seven dogs received injection of the <z:chebi fb="0" ids="35457">angiotensin converting enzyme inhibitor</z:chebi> teprotide and 3 control dogs received <z:mpath ids='MPATH_458'>normal</z:mpath> saline </plain></SENT>
<SENT sid="3" pm="."><plain>Repeat angiography at 30 and 90 minutes after injection, showed total or partial release of spasm in the experimental dogs and no change or further intensification of spasm in the control animals </plain></SENT>
<SENT sid="4" pm="."><plain>We concluded that angiotensin converting <z:e sem="disease" ids="C0877008" disease_type="Disease or Syndrome" abbrv="">enzyme inhibition</z:e> may be a potentially useful approach for the reversal or prevention of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral arteriospasm</z:e> after <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> </plain></SENT>
</text></document>